Table 2 Univariate and multivariate Cox regression analyses of clinicopathological features and SLC25A5 and SCL25A24 expression.

From: An integrated bioinformatic investigation of mitochondrial solute carrier family 25 (SLC25) in colon cancer followed by preliminary validation of member 5 (SLC25A5) in tumorigenesis

Variables

Univariate Cox analysis

Multivariate Cox analysis

p value

Hazard ratio

95% confidence interval

p value

Hazard ratio

95% confidence interval

Gender

0.085

1.739

0.926–3.263

/

/

/

Age

0.868

1.002

0.975–1.030

/

/

/

Tumor site

0.230

0.680

0.362–1.277

/

/

/

Pathological type

0.518

1.246

0.640–2.427

/

/

/

Pathological grade

0.026

2.057

1.091–3.880

0.098

1.862

0.891–3.891

Tumor size

0.148

1.590

0.848–2.983

/

/

/

Gross type

0.560

0.885

0.586–1.336

/

/

/

T stage

0.001

3.121

1.629–5.981

0.146

1.698

0.832–3.465

N stage

0.001

4.348

2.718–6.957

0.034

2.878

1.080–7.666

Num of lymph nodes

0.001

1.268

1.155–1.392

0.868

1.021

0.801–1.300

Preoperative CEA level

0.012

1.001

1.000–1.002

0.652

1.000

0.999–1.001

Preoperative CA199 level

0.001

1.006

1.002–1.009

0.934

1.000

0.993–1.007

Preoperative CA125 level

0.013

1.023

1.005–1.041

0.803

0.996

0.965–1.028

Preoperative AFP level

0.555

1.071

0.853–1.345

/

/

/

SLC25A5

0.001

0.275

0.141–0.535

0.040

0.444

0.205–0.963

SLC25A24

0.046

0.490

0.244–0.986

0.634

0.832

0.390–1.773

Back to article page